SCHEMBL4292887

SCHEMBL4292887

CC(=O)OCc1ccc(Cc2ccc(F)cc2)c(O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.49
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
ALDH1A1 P00352 1/20 0.44
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ALOX5 P09917 1/20 0.41
CA2 P00918 1/20 0.41
LMNA P02545 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HSP90AA1 P07900 2/20 0.40
HTT P42858 2/20 0.40
TP53 P04637 1/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HSP90B1 P14625 1/20 0.40
MIF P14174 1/20 0.40
IDH1 O75874 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4284205 0.92 CYP3A4 (0.53) CYP3A4MAOAMAOBALDH1A1MAPT
SCHEMBL4288729 0.88 CYP3A4 (0.49) CYP3A4MAOBALDH1A1MAPTMEN1
SCHEMBL3999055 0.88 CYP3A4 (0.49) CYP3A4ALDH1A1MAPTMEN1KMT2A
SCHEMBL4287021 0.87 KMT2A (0.50) CYP3A4MAOAMAOBALDH1A1MAPT
SCHEMBL4281466 0.87 CYP3A4 (0.48) CYP3A4ALDH1A1MAPTMEN1KMT2A
SCHEMBL4004352 0.86 CYP3A4 (0.47) CYP3A4ALDH1A1MAPTMEN1KMT2A
SCHEMBL4289242 0.86 CYP3A4 (0.47) CYP3A4ALDH1A1MEN1KMT2AHSP90AA1
SCHEMBL4292518 0.85 CYP3A4 (0.46) CYP3A4ALDH1A1MAPTMEN1KMT2A
SCHEMBL4284520 0.84 CYP3A4 (0.43) CYP3A4MAOAMAOBALDH1A1MAPT
SCHEMBL4288460 0.84 SLC6A4 (0.43) CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101472937-A Benzylphenylglucopyranoside Derivatives DAIICHI SANKYO CO LTD (JP) 2009-07-01 CN disclosed
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 CYP3A4 534/4885MAOA 3770/4885MAOB 3258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.